<?xml version="1.0" encoding="UTF-8"?>
<ref id="B51-brainsci-11-00259">
 <label>51.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Thancharoen</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Limwattananon</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Waleekhachonloet</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Rattanachotphanit</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Limwattananon</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Limpawattana</surname>
    <given-names>P.</given-names>
   </name>
  </person-group>
  <article-title>
   <italic>Ginkgo biloba</italic> Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimerâ€™s Disease: A Network Meta-Analysis
  </article-title>
  <source>Drugs Aging</source>
  <year>2019</year>
  <volume>36</volume>
  <fpage>435</fpage>
  <lpage>452</lpage>
  <pub-id pub-id-type="doi">10.1007/s40266-019-00648-x</pub-id>
  <pub-id pub-id-type="pmid">30937879</pub-id>
 </element-citation>
</ref>
